difficile as their primary diagnosis during the study period, with a median time to readmission of 23 days. ... The researchers concluded that C. difficile readmissions are relatively common, and that the noted risk factors could be used to identify and
The main outcome was 30-day readmissions, although researchers also looked at length of stay in BOOST units compared to control units. ... In the end, it seems unlikely that this iteration of the BOOST program produced broad reductions in readmission
were no significant differences in 60- and 90-day readmission rates or 30-day ED visit rates. ... may not be surprising, given lack of significant improvement in national readmission rates, the authors said.
Outpatient follow-up, readmission rates higher for direct-arrival vs. transferred-in MI patients, study finds
Likelihood of follow-up in an outpatient clinic and 30-day mortality and readmission risks were compared between patients who presented directly to a hospital with MI and those who were ... 14.0%; hazard ratio, 1.08; 95% CI, 1.01 to 1.15) and
When country-level LOS adjustments were made, U.S. location no longer predicted 30-day readmission, however. ... Private insurance paid for 47% of the 30-day readmissions, while Medicare paid for 40%.
readmissions. Patients who were consecutively admitted for acute decompensated heart failure at 19 secondary and tertiary hospitals between Oct.
They identified potentially avoidable 30-day readmissions using a computerized algorithm based on administrative data. ... Researchers randomly divided the admissions not followed by a 30-day readmission (n=8,333) and the potentially avoidable
SNFs were found to be associated with fewer readmissions compared with home care, a plus for both patients and hospitals. ... Medicare's Hospital Readmissions Reduction Program (HRRP), launched in 2012, penalizes hospitals with 30-day readmission rates
Lower glucose levels before hospital discharge associated with readmission, death in diabetes patients
However, levels below that range were associated with progressively increasing risk of readmission and mortality. ... 2 mg/dL (4.8 mmol/L) for the combined outcome of readmission or mortality within 30 days.
The intervention didn't reduce the combined outcome of ED visits and readmissions within 30, 90, or 180 days after discharge. ... Outcomes were readmission, death, ED visits, or nursing home admission within 30 days, 90 days, 6 months, and 1 year.